Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin ... form or as a disposable pen. Sanofi fights back This ...

Additionally, the rapid-acting insulin analogs segment is predicted to grow at the fastest CAGR during the forecast period ...

The global rapid acting insulin market was valued at $7,100 million in 2019, and is projected to reach $8,925 million by 2027 at a CAGR of 4.1% from 2020 to 2027. The growth of the global rapid acting ...

Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Patients with chronic pain treated with the novel Fast-Acting Sub-Perception Therapy (FAST) spinal cord stimulation (SCS) systems may achieve significant and durable pain relief for up to 12 ...

The companion app for the InPen digital insulin pen is designed to connect with the company’s latest Simplera continuous glucose monitor, offering users personalized dosing suggestions based on ...

The quickest way to lower your blood sugar is to take fast-acting insulin. However, if your readings stay high, it’s important to seek immediate medical support. High blood sugar levels ...

FRIDAY, Dec. 6, 2024 (HealthDay News) -- Patients with chronic pain treated with the novel Fast-Acting Sub-Perception Therapy (FAST) spinal cord stimulation (SCS) systems may achieve significant and ...